U.S. Court of Appeals for the Federal Circuit, 2024

Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc.

Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc.
U.S. Court of Appeals for the Federal Circuit · Decided September 3, 2024

Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc.

Opinion

Case: 23-2219 Document: 19 Page: 1 Filed: 09/03/2024

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellant v. TORRENT PHARMA INC., TORRENT PHARMACEUTICALS LTD., Defendants-Appellees ______________________ 2023-2219 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:19-cv-01979-RGA, Judge Richard G. Andrews. ______________________ ORDER Upon consideration of the parties’ joint stipulation of voluntary dismissal of this appeal, pursuant to Federal Rule of Appellate Procedure 42(b)(1), ECF No. 18, IT IS ORDERED THAT: (1) The appeal is voluntarily dismissed.

Case: 23-2219 Document: 19 Page: 2 Filed: 09/03/2024

2 NOVARTIS PHARMACEUTICALS CORPORATION v. TORRENT PHARMA INC.

(2) Each side shall bear its own costs.

FOR THE COURT

September 3, 2024 Date

ISSUED AS A MANDATE: September 3, 2024

Case-law data current through December 31, 2025. Source: CourtListener bulk data.